Carclo’s strategy is:
- To grow its specialist businesses, such as medical and LED optics and lighting
- To continue to expand in low cost regions
- To increase its investment in new technologies and proprietary know-how
In the year to 31 March 2012, this strategy helped deliver continued forward momentum.
- LED optics sales continue to grow
- Sales of medical components now account for 44% of group sales
- Design and development revenues for specialist lighting on the latest generation of supercars makes the group a world leader in the industry
- Group well balanced globally
- Conductive Inkjet Technology ("CIT") focused on Fine Line Touch project with Atmel Corporation with volume production shipments to multiple customers expected shortly
- Plans to develop further revenue streams from the CIT technology
- Carclo Diagnostic Solutions (“CDS”) has developed a range of highly novel single use point-of-care diagnostic devices